FRESENIUS SE & CO. KGAA Fresenius Helios closed its €5.76 billion acquisition of IDC Salud Holding S.L.U. ('Quirónsalud') today, as planned. Quirónsalud will be consolidated as of February 1, 2017.
Of the total purchase price for Spain's largest private hospital operator, €5.36 billion had already been debt-financed. The balance of €400 million was paid in the form of 6,108,176 new Fresenius shares issued today from authorized capital excluding subscription rights.
Quirónsalud's network is comprised of 43 hospitals, 39 outpatient centers and about 300 Occupational Risk Prevention centers located in all economically important areas of Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe's largest private hospital operator.
This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.
Fresenius SE & Co. KGaA published this content on 31 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 31 January 2017 15:49:02 UTC.
Original documenthttps://www.fresenius.com/5491
Public permalinkhttp://www.publicnow.com/view/459137AA1F991798AC7BAB222B897CDDDDC6711A
